Maria Grazia Roncarolo SEC EDGAR Filings (CIK 0001811671)

SEC EDGAR filings, ownership reports, and insider transactions for Maria Grazia Roncarolo.

Business address
C/O Atara Biotherapeutics, Inc., 611 Gateway Boulevard, Suite 900, South San Francisco, CA, 94080
Top holdings (ownership)
ATRA
Get insider transactions for this reporting owner
Maria Grazia Roncarolo has filed 7 SEC EDGAR filings since 12 May 2020

Latest Filings

Recent SEC filings for Maria Grazia Roncarolo including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 12 Jun 2025 10 Jun 2025 001-36548
4 Open 4 document View SEC filing for 4 02 Apr 2024 31 Mar 2024 001-36548
4 Open 4 document View SEC filing for 4 02 Jun 2023 31 May 2023 001-36548
4 Open 4 document View SEC filing for 4 FORM 4 27 Jun 2022 23 Jun 2022 001-36548
4 Open 4 document View SEC filing for 4 FORM 4 09 Jun 2021 08 Jun 2021 001-36548
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 12 May 2020 11 May 2020 001-36548
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 12 May 2020 11 May 2020 001-36548

About this filer

Maria Grazia Roncarolo files with the SEC under CIK 0001811671. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages